Search

everythinglearnresearchcommunity

for

Search:↓

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Alefacept does not effectively treat severe alopecia areata.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Methotrexate is generally safe and often effective for treating hair loss in children.

3D imaging effectively tracks skin changes in vitiligo treatment.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

EGFR inhibitors can cause yellowish skin eruptions.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

EREG therapy may help treat hair loss by promoting hair growth.

Ethylenthiourea is toxic to the liver and nervous system, especially with alcohol.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

The EG7 foam dressing improved wound healing and reduced inflammation better than other treatments.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.